Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Gut microbiota in health and disease: an overview focused on metabolic inflammation
in Beneficial MicrobesSearch for other papers by R. Nagpal in
Current site
Google Scholar
Search for other papers by M. Kumar in
Current site
Google Scholar
Search for other papers by A.K. Yadav in
Current site
Google Scholar
Search for other papers by R. Hemalatha in
Current site
Google Scholar
Search for other papers by H. Yadav in
Current site
Google Scholar
Search for other papers by F. Marotta in
Current site
Google Scholar
Search for other papers by Y. Yamashiro in
Current site
Google Scholar
In concern to the continuously rising global prevalence of obesity, diabetes and associated diseases, novel preventive and therapeutic approaches are urgently required. However, to explore and develop such innovative strategies, a meticulous comprehension of the biological basis of these diseases is extremely important. Past decade has witnessed an enormous amount of research investigation and advancement in the field of obesity, diabetes and metabolic syndrome, with the gut microbiota receiving a special focus in the triangle of nutrition, health and diseases. In particular, the role of gut microbiota in health and diseases has been one of the most vigorous and intriguing field of recent research; however, much still remains to be elucidated about its precise role in host metabolism and immune functions and its implication in the onset, progression as well as in the amelioration of metabolic ailments. Recent investigations have suggested a significant contribution of the gut microbiota in the regulation and impairment of energy homeostasis, thereby causing metabolic disorders, such as metabolic endotoxemia, insulin resistance and type 2 diabetes. Numerous inflammatory biomarkers have been found to be associated with obesity, diabetes and risk of other associated adverse outcomes, thereby suggesting that a persistent low-grade inflammatory response is a potential risk factor. In this milieu, this review intends to discuss potential evidences supporting the disturbance of the gut microbiota balance and the intestinal barrier permeability as a potential triggering factor for systemic inflammation in the onset and progression of obesity, type 2 diabetes and metabolic syndrome.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
-
Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., Chamontin, B. and Ferrieres. J. 2008. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 87: 1219-1223.
'Energy intake is associated with endotoxemia in apparently healthy men ' () 87 American Journal of Clinical Nutrition : 1219 -1223.
-
Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R. and Fernandes, G.R., 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
'Enterotypes of the human gut microbiome ' () 473 Nature : 174 -180.
-
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., Taniguchi, T., Takeda, K., Hori, S., Ivanov, I.I., Umesaki, Y., Itoh, K. and Honda, K., 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
'Induction of colonic regulatory T cells by indigenous Clostridium species ' () 331 Science : 337 -341.
-
Ayabe, T., Satchell, D.P., Wilson, C.L., Parks, W.C., Selsted, M.E. and Ouellette, AJ., 2000. Secretion of microbicidal alpha-defensins by intestinal paneth cells in response to bacteria. Nature Immunology 1: 113-118.
'Secretion of microbicidal alpha-defensins by intestinal paneth cells in response to bacteria ' () 1 Nature Immunology : 113 -118.
-
Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-23.
The gut microbiota as an environmental factor that regulates fat storage 101 15718 23
-
Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice 104 979 984
-
Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., Khan, M.T., Zhang, J., Li, J., Xiao, L., Al-Aama, J., Zhang, D., Lee, Y.S., Kotowska, D., Colding, C., Tremaroli, V., Yin, Y., Bergman, S., Xu, X., Madsen, L., Kristiansen, K., Dahlgren, J. and Wang, J., 2015. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17: 690-703.
'Dynamics and stabilization of the human gut microbiome during the first year of life ' () 17 Cell Host Microbe : 690 -703.
-
Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E. and Flint, H.J., 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Applied and Environmental Microbiology 72: 3593-3599.
'Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut ' () 72 Applied and Environmental Microbiology : 3593 -3599.
-
Bergstrom, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., Molgaard, C., Michaelsen, K.F. and Licht, T.R., 2014. Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants. Applied and Environmental Microbiology.
'Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants ' () Applied and Environmental Microbiology .
-
Bjorksten, B., Sepp, E., Julge, K., Voor, T. and Mikelsaar, M., 2001. Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology 108: 516-520.
'Allergy development and the intestinal microflora during the first year of life ' () 108 Journal of Allergy and Clinical Immunology : 516 -520.
-
Blaschitz, C. and Raffatellu, M., 2010. Th17 cytokines and the gut mucosal barrier. Journal of Clinical Immunology 30: 196-203.
'Th17 cytokines and the gut mucosal barrier ' () 30 Journal of Clinical Immunology : 196 -203.
-
Boleij, A. and Tjalsma, H., 2012. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biological reviews of the Cambridge Philosophical Society 87: 701-730.
'Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer ' () 87 Biological reviews of the Cambridge Philosophical Society : 701 -730.
-
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrie` res, J., Tanti, J,F., Gibson, G.R., Casteilla, L., Delzenne, N.M. and Alessi, M.C., 2007a. Burcelin r. metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
'Burcelin r. metabolic endotoxemia initiates obesity and insulin resistance ' () 56 Diabetes : 1761 -1772.
-
Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
'Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice ' () 57 Diabetes : 1470 -1481.
-
Cani, P.D., Hoste, S., Guiot, Y. and Delzenne, N.M., 2007b. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. British Journal of Nutrition 98: 32-37.
'Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats ' () 98 British Journal of Nutrition : 32 -37.
-
Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M. and Burcelin, R., 2006. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide1receptor. Diabetes 55: 1484-1490.
'Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide1receptor ' () 55 Diabetes : 1484 -1490.
-
Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., De Backer, F., Neyrinck, A.M. and Delzenne, N.M., 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. American Journal of Clinical Nutrition 90: 1236-1243.
'Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal ' () 90 American Journal of Clinical Nutrition : 1236 -1243.
-
Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G. and Delzenne N.M., 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
'Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability ' () 58 Gut : 1091 -1103.
-
Carding, S., Verbeke, K., Vipond, D.T., Corfe, B.M. and Owen, L. J., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26: 26191.
'Dysbiosis of the gut microbiota in disease ' () 26 Microbial Ecology in Health and Disease : 26191.
-
Childs, C.E., Röytiö, H., Alhoniemi, E., Fekete, A.A., Forssten, S.D., Hudjec, N., Lim, Y.N., Steger, C.J., Yaqoob, P., Tuohy, K.M., Rastall, R.A., Ouwehand, A.C. and Gibson, G.R., 2014. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. British Journal of Nutrition 24: 1-12.
'Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study ' () 24 British Journal of Nutrition : 1 -12.
-
Clarke S.F., Murphy, E.F., O’Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Hayes, P., O’Reilly, M., Jeffery, I.B., Wood-Martin, R., Kerins, D.M., Quigley, E., Ross, R.P., O’Toole, P.W., Molloy, M.G., Falvey, E., Shanahan, F., and Cotter, P.D., 2014. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63: 1913-1920.
'Exercise and associated dietary extremes impact on gut microbial diversity ' () 63 Gut : 1913 -1920.
-
Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y. and Weiser, J.N., 2010. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 16: 228-231.
'Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity ' () 16 Nature Medicine : 228 -231.
-
Cox, L.M., Yamanishi, S., Sohn, J., Alekseyenko, A.V., Leung, J.M., Cho, I., Kim, S.G., Li, H., Gao, Z., Mahana, D., Zárate, J.G., Rogers, A.B., Robine, N., Loke, P. and Blaser, M.J., 2014. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158: 705-721.
'Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences ' () 158 Cell : 705 -721.
-
Davenport, E.R., Mizrahi-Man, O., Michelini, K., Barreiro, L.B., Ober, C. and Gilad, Y., 2014. Seasonal variation in human gut microbiome composition. PLoS One 9: e90731.
'Seasonal variation in human gut microbiome composition ' () 9 PLoS One : e90731.
-
David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J. and Turnbaugh, P.J., 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
'Diet rapidly and reproducibly alters the human gut microbiome ' () 505 Nature : 559 -563.
-
Dethlefsen, L., Eckburg, P. B., Bik, E.M. and Relman, D.A., 2006. Assembly of the human intestinal microbiota. Trends in Ecology and Evolution 21: 517-523.
'Assembly of the human intestinal microbiota ' () 21 Trends in Ecology and Evolution : 517 -523.
-
Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C. and Lund, P.K., 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5: e12191.
'High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse ' () 5 PLoS One : e12191.
-
Dridi, B., M. Henry, Khéchine, E.l., Raoult, D. and Drancourt, M., 2009. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 4: e7063.
'High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol ' () 4 PLoS One : e7063.
-
Duncan, S. H., P. Louis. and Flint, H.J., 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 70: 5810-5817.
'Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product ' () 70 Applied and Environmental Microbiology : 5810 -5817.
-
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. and Relman, D.A., 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
'Diversity of the human intestinal microbial flora ' () 308 Science : 1635 -1638.
-
Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I. and Flavell, R.A., 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
'NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis ' () 145 Cell : 745 -757.
-
Endesfelder, D., Castell, W.Z., Ardissone, A., Davis-Richardson, A.G., Achenbach, P., Hagen, M., Pflueger, M., Gano, K.A., Fagen, J.R., Drew, J.C., Brown, C.T., Kolaczkowski, B., Atkinson, M., Schatz, D., Bonifacio, E., Triplett, E.W. and Ziegler, A.G., 2014. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63: 2006-2014.
'Compromised gut microbiota networks in children with anti-islet cell autoimmunity ' () 63 Diabetes : 2006 -2014.
-
Erejuwa, O.O., Sulaiman, S.A. and Wahab, M.S., 2014. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. International Journal of Molecular Science 15: 4158-4188.
'Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges ' () 15 International Journal of Molecular Science : 4158 -4188.
-
Faith, J.J., Guruge, J.L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A.L., Clemente, J.C., Knight, R., Heath, A.C., Leibel R.L., Rosenbaum, M. and Gordon, J.I., 2013. The long-term stability of the human gut microbiota. Science 341: 1237439.
'The long-term stability of the human gut microbiota ' () 341 Science : 1237439.
-
Flint, H.J., Duncan, S.H., Scott, K.P. and Louis, P., 2007. Interactions and competition within the microbial community of the human colon: links between diet and health. Environmental Microbiology 9: 1101-1111.
'Interactions and competition within the microbial community of the human colon: links between diet and health ' () 9 Environmental Microbiology : 1101 -1111.
-
Fritz, J.H., Le Bourhis, L., Sellge, G., Magalhaes, J.G., Fsihi, H. and Kufer, T.A., 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26: 445-459.
'Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity ' () 26 Immunity : 445 -459.
-
Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
'Probiotics in man and animals ' () 66 Journal of Applied Bacteriology : 365 -378.
-
Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, G., Dore, J., Henegar, C., Rizkalla, S. and Clément, K., 2010. Differential adaptation of human gut microbiota to bariatric surgery induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
'Differential adaptation of human gut microbiota to bariatric surgery induced weight loss: links with metabolic and low-grade inflammation markers ' () 59 Diabetes : 3049 -3057.
-
Gangloff, S.C., Hijiya, N., Haziot, A. and Goyert, S.M., 1999. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clinical Infectious Diseases 28: 491-496.
'Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways ' () 28 Clinical Infectious Diseases : 491 -496.
-
Ghanim, H., Abuaysheh, S., Sia, C.L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J.M. and Dandona, P., 2009. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281-2287.
'Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance ' () 32 Diabetes Care : 2281 -2287.
-
Ghanim, H., Sia, C.L., Upadhyay, M., Korzeniewski, K., Viswanathan, P., Abuaysheh, S., Mohanty, P. and Dandona, P., 2010. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. American Journal of Clinical Nutrition 91: 940-949.
'Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression ' () 91 American Journal of Clinical Nutrition : 940 -949.
-
Ghoshal, S., Witta, J., Zhong, J., De Villiers, W. and Eckhardt, E., 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 50: 90-97.
'Chylomicrons promote intestinal absorption of lipopolysaccharides ' () 50 Journal of Lipid Research : 90 -97.
-
Gibson, G.R. and Roberfroid, M.B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
'Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics ' () 125 Journal of Nutrition : 1401 -1412.
-
Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M. and Nelson, K.E., 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
'Metagenomic analysis of the human distal gut microbiome ' () 312 Science : 1355 -1359.
-
Gonzalez-Navajas, J.M., Bellot, P., Francés, R., Zapater, P., Muñoz, C., García-Pagán, J.C., Pascual, S., Pérez-Mateo, M., Bosch, J. and Such, J., 2008. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. Journal of Hepatology 48: 61-67.
'Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin ' () 48 Journal of Hepatology : 61 -67.
-
Graessler, J., Qin, Y., Zhong, H., Zhang, J., Licinio, J., Wong, M.L., Xu, A., Chavakis, T., Bornstein, A.B., Ehrhart-Bornstein, M., Lamounier-Zepter, V., Lohmann, T., Wolf, T. and Bornstein, S.R., 2012. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics Journal 13: 514-522.
'Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters ' () 13 Pharmacogenomics Journal : 514 -522.
-
Guida, S and Venema, K., 2015. Gut microbiota and obesity: involvement of the adipose tissue. Journal of Functional Foods 14: 407-423.
'Gut microbiota and obesity: involvement of the adipose tissue ' () 14 Journal of Functional Foods : 407 -423.
-
Harmsen, H.J., Wildeboer-Veloo, A.C., Wagendorp, A.A., Bindels, J.G. and Welling, G.W., 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition 30: 61-67.
'Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods ' () 30 Journal of Pediatric Gastroenterology and Nutrition : 61 -67.
-
Hentges, D.J., 1993. The anaerobic microflora of the human-body. Clinical Infectious Diseases 16: S175-S180.
'The anaerobic microflora of the human-body ' () 16 Clinical Infectious Diseases : S175 -S180.
-
Hold, G.L., Smith, M., Grange, C., Watt, E.R., El-Omar, E.M. and Mukhopadhya, I., 2014. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World Journal of Gastroenterology 20: 1192-1210.
'Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? ' () 20 World Journal of Gastroenterology : 1192 -1210.
-
Kalliomaki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 87: 534-538.
'Early differences in fecal microbiota composition in children may predict overweight ' () 87 American Journal of Clinical Nutrition : 534 -538.
-
Kelishadi, R., Farajian, S., Safavi, M., Mirlohi, M. and Hashemipour, M., 2014. A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children. Journal of Paediatrics 90: 161-168.
'A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children ' () 90 Journal of Paediatrics : 161 -168.
-
Khosravi, A. and Mazmanian, S.K., 2013. Disruption of the gut microbiome as a risk factor for microbial infections. Current Opinions in Microbiology 16: 221-227.
'Disruption of the gut microbiome as a risk factor for microbial infections ' () 16 Current Opinions in Microbiology : 221 -227.
-
Khosravi, A., Yanez, A., Price, J.G., Chow, A., Merad, M., Goodridge, H.S. and Mazmanian, S.K., 2014. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 15: 374-381.
'Gut microbiota promote hematopoiesis to control bacterial infection ' () 15 Cell Host Microbe : 374 -381.
-
King, S., Glanville, J., Sanders, M.E., Fitzgerald, A. and Varley, D., 2014. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. British Journal of Nutrition 29: 1-14.
'Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis ' () 29 British Journal of Nutrition : 1 -14.
-
Konig, J. and Brummer, R.J., 2014. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 5: 247-261.
'Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome ' () 5 Beneficial Microbes : 247 -261.
-
Kumar, M., Kumar, A., Nagpal, R., Mohania, D., Behare, P., Verma, V., Kumar, P., Poddar, D., Aggarwal, P.K., Henry, C.J, Jain, S. and Yadav, H., 2010. Cancer-preventing attributes of probiotics: an update. International Journal of Food Science and Nutrition 61: 473-496.
'Cancer-preventing attributes of probiotics: an update ' () 61 International Journal of Food Science and Nutrition : 473 -496.
-
Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C., Singh, B., Marotta, F., Jain, S. and Yadav, H., 2012a. Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012: 902917.
'Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases ' () 2012 Experimental Diabetes Research : 902917.
-
Kumar, M., Nagpal, R., Verma, V., Kumar, A., Kaur, N., Hemalatha, R., Gautam, S. and Singh, B., 2013a. The probiotic metabolites as epigenetic target to control colon cancer. Nutrition Reviews 71: 23-34.
'The probiotic metabolites as epigenetic target to control colon cancer ' () 71 Nutrition Reviews : 23 -34.
-
Kumar, M., Rakesh, S., Nagpal, R., Kumar, R., Hemalatha, R., Ramakrishna, A., Sudarshan, V., Ramagoni, R., Shujauddin, M., Verma, V., Kumar, A., Tiwari, A. and Singh, B., 2013b. Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improves lipid profiles in hypercholesterolemic rats. Nutrition 29: 574-579.
'Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improves lipid profiles in hypercholesterolemic rats ' () 29 Nutrition : 574 -579.
-
Kumar, M., Verma, V., Nagpal, R., Kumar, A., Behare, P.V., Singh, B. and Aggarwal, P.K., 2012b. Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats. British Journal of Nutrition 107: 1006-1016.
'Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats ' () 107 British Journal of Nutrition : 1006 -1016.
-
Kumar, M., Verma, V., Nagpal, R., Kumar, A., Gautam, S.K., Behare, P.V., Grover, C.R. and Aggarwal, P.K., 2011. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma. Gene 490: 54-59.
'Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma ' () 490 Gene : 54 -59.
-
Kunisawa, J. and Kiyono, H., 2012. Immune regulation and monitoring at the epithelial surface of the intestine. Drug Discovery Today 18: 87-92.
'Immune regulation and monitoring at the epithelial surface of the intestine ' () 18 Drug Discovery Today : 87 -92.
-
Lee, C.Y., 2013. The effect of high-fat diet-induced pathophysiological changes in the gut on obesity: what should be the ideal treatment? Clinical and Translational Gastroenterology 11: 4.
'The effect of high-fat diet-induced pathophysiological changes in the gut on obesity: what should be the ideal treatment? ' () 11 Clinical and Translational Gastroenterology : 4.
-
Ley, R.E., 2010. Obesity and the human microbiome. Current Opinions in Gastroenterology 26: 5-11.
'Obesity and the human microbiome ' () 26 Current Opinions in Gastroenterology : 5 -11.
-
Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075.
'Obesity alters gut microbial ecology ' () 102 Proceedings of the National Academy of Sciences of the USA : 11070 -11075.
-
Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
'Microbial ecology: human gut microbes associated with obesity ' () 444 Nature : 1022 -1023.
-
Lozupone, C., Stombaugh, J., Gonzalez, A., Ackermann, G., Wendel, D., Vázquez-Baeza, Y., Jansson, J.K., Gordon, J.I. and Knight, R., 2013. Meta-analyses of studies of the human microbiota. Genome Research 23: 1704-1714.
'Meta-analyses of studies of the human microbiota ' () 23 Genome Research : 1704 -1714.
-
Lundell, A.C., Rabe, H., Quiding-Järbrink, M., Andersson, K., Nordström, I., Adlerberth, I., Wold, A.E. and Rudin, A., 2011. Development of gut-homing receptors on circulating B cells during infancy. Clinical Immunology 138: 97-106.
'Development of gut-homing receptors on circulating B cells during infancy ' () 138 Clinical Immunology : 97 -106.
-
Ma, J., Prince, A.L., Bader, D., Hu, M., Ganu, R., Baquero, K., Blundell, P., Alan Harris, R., Frias, A.E., Grove, K.L. and Aagaard, K.M., 2014. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nature Communications 20: 3889.
'High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model ' () 20 Nature Communications : 3889.
-
Macfarlane, G.T. and Macfarlane, S., 2007. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Current Opinions in Biotechnology 18: 156-162.
'Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut ' () 18 Current Opinions in Biotechnology : 156 -162.
-
Macfarlane, G.T., Cummings J.H. and Allison, C., 1986. Protein-Degradation by human intestinal bacteria. Journal of General Microbiology 132: 1647-1656.
'Protein-Degradation by human intestinal bacteria ' () 132 Journal of General Microbiology : 1647 -1656.
-
Macfarlane, S., Bahrami, B. and Macfarlane, G.T., 2011. Mucosal biofilm communities in the human intestinal tract. Advances in Applied Microbiology 75: 111-143.
'Mucosal biofilm communities in the human intestinal tract ' () 75 Advances in Applied Microbiology : 111 -143.
-
Macfarlane, S., Steed, H. and Macfarlane, G.T., 2009. Intestinal bacteria and inflammatory bowel disease. Critical Reviews in Clinical Laboratory Science 46: 25-54.
'Intestinal bacteria and inflammatory bowel disease ' () 46 Critical Reviews in Clinical Laboratory Science : 25 -54.
-
Mayer, E.A., Savidge, T. and Shulman, R.J., 2014. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146: 1500-1512.
'Brain-gut microbiome interactions and functional bowel disorders ' () 146 Gastroenterology : 1500 -1512.
-
Menard, S., Förster, V., Lotz, M., Gütle, D., Duerr, C.U., Gallo, R.L., Henriques-Normark, B., Pütsep, K., Andersson, M., Glocker, E.O. and Hornef, M.W., 2008. Developmental switch of intestinal antimicrobial peptide expression. Journal of Experimental Medicine 205: 183-193.
'Developmental switch of intestinal antimicrobial peptide expression ' () 205 Journal of Experimental Medicine : 183 -193.
-
Metchnikoff, E., 1907. The prolongation of life. Optimistic studies. William Heinemann, London, UK.
'The prolongation of life ', in Optimistic studies , ().
-
Muccioli, G.G., Naslain, D., Bäckhed, F., Reigstad, C.S, Lambert, D.M., Delzenne, N.M and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
'The endocannabinoid system links gut microbiota to adipogenesis ' () 6 Molecular Systems Biology : 392.
-
Musso, G., Gambino, R. and Cassader, M., 2011. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annual Reviews in Medicine 62: 361-380.
'Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes ' () 62 Annual Reviews in Medicine : 361 -380.
-
Myles, I.A., Pincus, N.B., Fontecilla, N.M. and Datta, S.K., 2014. Effects of parental omega-3 fatty acid intake on offspring microbiome and immunity. PLoS One 9: e87181.
'Effects of parental omega-3 fatty acid intake on offspring microbiome and immunity ' () 9 PLoS One : e87181.
-
Nagpal, R., Kumar, A., Kumar, M., Behare, P.V., Jain, S. and Yadav, H., 2012. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiology Letters 334: 1-15.
'Probiotics, their health benefits and applications for developing healthier foods: a review ' () 334 FEMS Microbiology Letters : 1 -15.
-
Nagpal, R., Yadav, H. and Marotta, F., 2014. Gut microbiota: the next-gen frontier in preventive and therapeutic medicine? Frontiers in Medicine 1: 15.
'Gut microbiota: the next-gen frontier in preventive and therapeutic medicine? ' () 1 Frontiers in Medicine : 15.
-
Nagpal, R., Yadav, H., Puniya, A.K., Singh, K., Jain, S. and Marotta, F., 2007. Potential of probiotics and prebiotics for synbiotic functional dairy foods. International Journal of Probiotics and Prebiotics 2: 75-84.
'Potential of probiotics and prebiotics for synbiotic functional dairy foods ' () 2 International Journal of Probiotics and Prebiotics : 75 -84.
-
Neufeld, K.M., Kang, N., Bienenstock, J. and Foster, J.A., 2011. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterology and Motility 23: 255-264.
'Reduced anxiety-like behavior and central neurochemical change in germ-free mice ' () 23 Neurogastroenterology and Motility : 255 -264.
-
Png, C.W., Lindén, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., McGuckin, M.A. and Florin, T.H., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. American Journal of Gastroenterology 105: 2420-2428.
'Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria ' () 105 American Journal of Gastroenterology : 2420 -2428.
-
Podolsky, D.K., 1991. Inflammatory bowel disease (1). New England Journal of Medicine 325: 928-937.
'Inflammatory bowel disease (1). ' () 325 New England Journal of Medicine : 928 -937.
-
Rabot, S., Membrez, M., Bruneau, A., Gérard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
'Germ-free C57BL/6J mice are resistant to high-fat-diet induced insulin resistance and have altered cholesterol metabolism ' () 24 FASEB Journal : 4948 -4959.
-
Rajilic-Stojanovic, M., Smidt, H. and De Vos, W.M., 2007. Diversity of the human gastrointestinal tract microbiota revisited. Environmental Microbiology 9: 2125-2136.
'Diversity of the human gastrointestinal tract microbiota revisited ' () 9 Environmental Microbiology : 2125 -2136.
-
Robert, C. and Bernalier-Donadille, A., 2003. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiology and Ecology 46: 81-89.
'The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects ' () 46 FEMS Microbiology and Ecology : 81 -89.
-
Rossi, O., Van Baarlen, P. and Wells, J.M., 2013. Host-recognition of pathogens and commensals in the mammalian intestine. Current Topics in Microbiology and Immunology 358: 291-321.
'Host-recognition of pathogens and commensals in the mammalian intestine ' () 358 Current Topics in Microbiology and Immunology : 291 -321.
-
Salazar, N., Dewulf, E.M., Neyrinck, A.M., Bindels, L.B., Cani, P.D., Mahillon, J., De Vos, W.M., Thissen, J.P., Gueimonde, M., De los Reyes-Gavilán, C.G. and Delzenne, N.M., 2014. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical Nutrition 34: 501-507.
'Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women ' () 34 Clinical Nutrition : 501 -507.
-
Salminen, S., Gibson, G.R., McCartney A.L. and Isolauri, E., 2004. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53: 1388-1389.
'Influence of mode of delivery on gut microbiota composition in seven year old children ' () 53 Gut : 1388 -1389.
-
Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. and Gordon, J.I., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772.
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein coupled receptor, Gpr41 105 16767 16772
-
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani, Y., Fukuda, H., Nomoto, K., Takahashi, T., Asahara, T., Hirose, T., Nagata, S., Yamashiro, Y. and Watada, H., 2014. Gut dysbiosis and detection of ‘live gut bacteria’ in blood of Japanese patients with type 2 diabetes. Diabetes Care 37: 2343-2350.
'Gut dysbiosis and detection of ‘live gut bacteria’ in blood of Japanese patients with type 2 diabetes ' () 37 Diabetes Care : 2343 -2350.
-
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
'Microbiota and SCFA in lean and overweight healthy subjects ' () 18 Obesity : 190 -195.
-
Sekirov, I., Russell, S.L., Antunes, L.C. and Finlay, B.B., 2010. Gut microbiota in health and disease. Physiological Reviews 90: 859-904.
'Gut microbiota in health and disease ' () 90 Physiological Reviews : 859 -904.
-
Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H. and Flier, J.S., 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigations 116: 3015-3025
'TLR4 links innate immunity and fatty acid-induced insulin resistance ' () 116 Journal of Clinical Investigations : 3015 -3025.
-
Sokol, H., Lay, C., Seksik, P. and Tannock, G.W., 2008. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflammatory Bowel Diseases 14: 858-867.
'Analysis of bacterial bowel communities of IBD patients: what has it revealed? ' () 14 Inflammatory Bowel Diseases : 858 -867.
-
Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P. and Doré, J., 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory Bowel Diseases 15: 1183-1189.
'Low counts of Faecalibacterium prausnitzii in colitis microbiota ' () 15 Inflammatory Bowel Diseases : 1183 -1189.
-
Soyucen, E., Gulcan, A., Aktuglu-Zeybek, A.C., Onal, H., Kiykim, E. and Aydin, A., 2013. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatrics International 56: 336-343.
'Differences in the gut microbiota of healthy children and those with type 1 diabetes ' () 56 Pediatrics International : 336 -343.
-
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S.C. and Bergheim, I., 2009. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104.
'Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice ' () 50 Hepatology : 1094 -1104.
-
Stefka, A.T., Feehley, T., Tripathi, P., Qiu, J., McCoy, K., Mazmanian, S.K., Tjota, M.Y., Seo, G.Y., Cao, S., Theriault, B.R., Antonopoulos, D.A., Zhou, L., Chang, E.B., Fu, Y.X., Nagler, C.R., 2014. Commensal bacteria protect against food allergen sensitization. Proceedings of the National Academy of Sciences of the USA 111: 13145-13150.
Commensal bacteria protect against food allergen sensitization 111 13145 13150
-
Tannock, G.W., 2002. The bifidobacterial and Lactobacillus microflora of humans. Clinical Reviews in Allergy and Immunology 22: 231-253.
'The bifidobacterial and Lactobacillus microflora of humans ' () 22 Clinical Reviews in Allergy and Immunology : 231 -253.
-
Tremaroli, V. and Backhed, F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
'Functional interactions between the gut microbiota and host metabolism ' () 489 Nature : 242 -249.
-
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
'An obesity-associated gut microbiome with increased capacity for energy harvest ' () 444 Nature : 1027 -1031.
-
Vaarala, O., Atkinson, M.A., Neu, J., 2008. The ‘perfect storm’ for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
'The ‘perfect storm’ for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity ' () 57 Diabetes : 2555 -2562.
-
Van den Abbeele, P., Van de Wiele, T., Verstraete, W. and Possemiers, S., 2011. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiology Reviews 35: 681-704.
'The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept ' () 35 FEMS Microbiology Reviews : 681 -704.
-
Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S. and Srinivasan, S., 2010. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328: 228-231.
'Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5 ' () 328 Science : 228 -231.
-
Wallace, T.C., Guarner, F., Madsen, K., Cabana, M.D., Gibson, G., Hentges, E. and Sanders, M.E., 2011. Human gut microbiota and its relationship to health and disease. Nutrition Reviews 69: 392-403.
'Human gut microbiota and its relationship to health and disease ' () 69 Nutrition Reviews : 392 -403.
-
Woodmansey, E.J., 2007. Intestinal bacteria and ageing. Journal of Applied Microbiology 102 1178-1186.
'Intestinal bacteria and ageing ' () 102 Journal of Applied Microbiology : 1178 -1186.
-
Xavier, R.J. and Podolsky, D.K., 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
'Unravelling the pathogenesis of inflammatory bowel disease ' () 448 Nature : 427 -434.
-
Yadav, H., Jain, S. and Sinha, P.R., 2007. Antidiabetic effect of probiotic Dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23: 62-68.
'Antidiabetic effect of probiotic Dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats ' () 23 Nutrition : 62 -68.
-
Yadav, H., Jain, S. and Sinha, P.R., 2008. Oral administration of Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. Journal of Dairy Research 75: 189-195.
'Oral administration of Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats ' () 75 Journal of Dairy Research : 189 -195.
-
Yadav, H., Lee, J.H., Lloyd, J., Walter, P. and Rane, S.G., 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288: 25088-25097.
'Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion ' () 288 Journal of Biological Chemistry : 25088 -25097.
-
Zeng, H., Lazarova, D.L. and Bordonaro, M., 2014. Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World Journal of Gastrointestinal Oncology 6: 41-51.
'Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention ' () 6 World Journal of Gastrointestinal Oncology : 41 -51.
-
Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., Danna, S.C., Tripathy, S., Hegsted, M. and Keenan, M.J., 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. The American Journal of Physiology: Endocrinology and Metabolism 295: E1160-E1166.
'Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents ' () 295 The American Journal of Physiology: Endocrinology and Metabolism : E1160 -E1166.
-
Zoetendal, E.G., Akkermans, A.D.L., Vliet, W.M.A., Visser, J.A.G M. and De Vos, W.M., 2001. The host genotype affects the bacterial community in the human gastronintestinal tract. Microbiology and Ecology in Health and Disease 13: 129-134.
'The host genotype affects the bacterial community in the human gastronintestinal tract ' () 13 Microbiology and Ecology in Health and Disease : 129 -134.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1547 | 381 | 32 |
| Gesamttextansichten | 145 | 37 | 0 |
| PDF-Downloads | 40 | 3 | 0 |
Gut microbiota in health and disease: an overview focused on metabolic inflammation
in Beneficial MicrobesSearch for other papers by R. Nagpal in
Current site
Google Scholar
PubMed
Search for other papers by M. Kumar in
Current site
Google Scholar
PubMed
Search for other papers by A.K. Yadav in
Current site
Google Scholar
PubMed
Search for other papers by R. Hemalatha in
Current site
Google Scholar
PubMed
Search for other papers by H. Yadav in
Current site
Google Scholar
PubMed
Search for other papers by F. Marotta in
Current site
Google Scholar
PubMed
Search for other papers by Y. Yamashiro in
Current site
Google Scholar
PubMed
In concern to the continuously rising global prevalence of obesity, diabetes and associated diseases, novel preventive and therapeutic approaches are urgently required. However, to explore and develop such innovative strategies, a meticulous comprehension of the biological basis of these diseases is extremely important. Past decade has witnessed an enormous amount of research investigation and advancement in the field of obesity, diabetes and metabolic syndrome, with the gut microbiota receiving a special focus in the triangle of nutrition, health and diseases. In particular, the role of gut microbiota in health and diseases has been one of the most vigorous and intriguing field of recent research; however, much still remains to be elucidated about its precise role in host metabolism and immune functions and its implication in the onset, progression as well as in the amelioration of metabolic ailments. Recent investigations have suggested a significant contribution of the gut microbiota in the regulation and impairment of energy homeostasis, thereby causing metabolic disorders, such as metabolic endotoxemia, insulin resistance and type 2 diabetes. Numerous inflammatory biomarkers have been found to be associated with obesity, diabetes and risk of other associated adverse outcomes, thereby suggesting that a persistent low-grade inflammatory response is a potential risk factor. In this milieu, this review intends to discuss potential evidences supporting the disturbance of the gut microbiota balance and the intestinal barrier permeability as a potential triggering factor for systemic inflammation in the onset and progression of obesity, type 2 diabetes and metabolic syndrome.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1547 | 381 | 32 |
| Gesamttextansichten | 145 | 37 | 0 |
| PDF-Downloads | 40 | 3 | 0 |
